UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast phyllodes tumor: A review of literature and a single center retrospective series analysis

Critical reviews in oncology/hematology, 2013-11, Vol.88 (2), p.427-436

2013

Volltextzugriff (PDF)

Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1867-1874

2005

Volltextzugriff (PDF)

Dendritic cell sarcoma: An analytic overview of the literature and presentation of original five cases

Critical reviews in oncology/hematology, 2008-01, Vol.65 (1), p.1-7

2008

Volltextzugriff (PDF)

Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer

Clinical lung cancer, 2016-09, Vol.17 (5), p.e179-e183

2016

Volltextzugriff (PDF)

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)

OncoTargets and therapy, 2015-08, Vol.8, p.1997-2003

2015

Volltextzugriff (PDF)

Integrative oncology and patients refusing conventional anticancer treatments

Complementary therapies in clinical practice, 2022-08, Vol.48, p.101608-101608, Article 101608

2022

Volltextzugriff (PDF)

Modulation of Epidermal Growth Factor Receptor Status by Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Is Rare

Journal of clinical oncology, 2004-12, Vol.22 (24), p.4966-4970

2004

Volltextzugriff (PDF)

Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy

The journal of alternative and complementary medicine (New York, N.Y.), 2018-09, Vol.24 (9-10), p.933-941

2018

Volltextzugriff (PDF)

A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma

European journal of cancer (1990), 2013-01, Vol.49 (2), p.290-296

2013

Volltextzugriff (PDF)

Patients refusing anticancer treatments and Complementary and Integrative Medicine

European journal of integrative medicine, 2021-12, Vol.48, p.102039, Article 102039

2021

Volltextzugriff (PDF)

A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors

Clinical cancer research, 2016-05, Vol.22 (9), p.2146-2154

2016

Volltextzugriff (PDF)

EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung

Lung cancer (Amsterdam, Netherlands), 2013-09, Vol.81 (3), p.440-444

2013

Volltextzugriff (PDF)

Integrating conventional and complementary treatments in cancer care: The process within the public healthcare system of the region of Tuscany, Italy

Complementary therapies in clinical practice, 2023-05, Vol.51, p.101738-101738, Article 101738

2023

Volltextzugriff (PDF)

Abstract 2635: Baseline myeloid-derived suppressor cell and eosinophil cell counts predict clinical efficacy in patients with non-small cell lung cancer (NSCLC) treated with nivolumab in second line

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2635-2635

2017

Volltextzugriff (PDF)

Implementing an Integrative Oncology Paradigm in Cancer Care: The Tuscan Regional Healthcare System

Journal of Integrative and Complementary Medicine, 2022-12, Vol.28 (12), p.965-968

2022

Volltextzugriff (PDF)

Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options

Critical reviews in oncology/hematology, 2014-03, Vol.89 (3), p.358-365

2014

Volltextzugriff (PDF)

Severity of Radiodermatitis in Breast Cancer Patients with Preventive Treatment with an Homeopathic/Integrative Protocol Compared with a Control Group

Homeopathy, 2020, Vol.109 (1)

2020

Volltextzugriff (PDF)

A Randomized Controlled Study on Cognitive Effects of Anti-cancer Therapy in Patients with Breast Cancer Treated with Rehabilitation Exercises, Diet and Add-on Homeopathy and Acupuncture/Auriculotherapy

Homeopathy, 2020, Vol.109 (1)

2020

Volltextzugriff (PDF)

Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?

Journal of thoracic disease, 2016-03, Vol.8 (3), p.E217-E220

2016

Volltextzugriff (PDF)

Afatinib for the first-line treatment of patients with metastatic EGFR-positive NSCLC: a look at the data

Expert review of clinical pharmacology, 2016-10, Vol.9 (10), p.1283-1288

2016

Volltextzugriff (PDF)

Erlotinib Efficacy in NSCLC Patients with High Polysomy of Chromosome 7 and EGFR/KRas Wild-Type Tumors

Journal of thoracic oncology, 2015-02, Vol.10 (2), p.392-396

2015

Volltextzugriff (PDF)

Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires—an Italian exploratory study

Journal of cancer research and clinical oncology, 2016-03, Vol.142 (3), p.633-648

2016

Volltextzugriff (PDF)

Homeopathy and Complementary Integrative Medicine, Dietary and Lifestyle Advices to Reduce Adverse-Effects of Anti-Cancer Therapy: A Cohort Study with Breast Cancer Patients

OBM Integrative and Complementary Medicine, 2018-09, Vol.3 (3), p.1-1

2018

Volltextzugriff (PDF)

P3.02c-094 Italian Nivolumab Advanced Squamous NSCLC Expanded Access Program: Efficacy and Safety in Patients with Brain Metastases

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1336

2017

Volltextzugriff (PDF)

P2.01-044 Baseline Peripheral Blood Cell Subsets Associated with Survival Outcomes in Advanced NSCLC Treated with Nivolumab in Second-Line Setting

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S812

2017

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(65)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Humans
(35)
Oncology
(34)
Female
(23)
Middle Aged
(20)
Aged
(19)
Male
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Adult
(13)
Antineoplastic Agents - Therapeutic Use
(12)
Lung Neoplasms - Drug Therapy
(10)
Tumors
(10)
Aged, 80 And Over
(8)
Hematology, Oncology And Palliative Medicine
(8)
Breast Cancer
(7)
Breast Neoplasms - Drug Therapy
(7)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(7)
Prognosis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Breast phyllodes tumor: A review of literature and a single center retrospective series analysis

Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails

Dendritic cell sarcoma: An analytic overview of the literature and presentation of original five cases

Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)

Integrative oncology and patients refusing conventional anticancer treatments

Modulation of Epidermal Growth Factor Receptor Status by Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Is Rare

Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy

A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma

Patients refusing anticancer treatments and Complementary and Integrative Medicine

A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors

EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung

Integrating conventional and complementary treatments in cancer care: The process within the public healthcare system of the region of Tuscany, Italy

Abstract 2635: Baseline myeloid-derived suppressor cell and eosinophil cell counts predict clinical efficacy in patients with non-small cell lung cancer (NSCLC) treated with nivolumab in second line

Implementing an Integrative Oncology Paradigm in Cancer Care: The Tuscan Regional Healthcare System

Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options

Severity of Radiodermatitis in Breast Cancer Patients with Preventive Treatment with an Homeopathic/Integrative Protocol Compared with a Control Group

A Randomized Controlled Study on Cognitive Effects of Anti-cancer Therapy in Patients with Breast Cancer Treated with Rehabilitation Exercises, Diet and Add-on Homeopathy and Acupuncture/Auriculotherapy

Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?

Afatinib for the first-line treatment of patients with metastatic EGFR-positive NSCLC: a look at the data

Erlotinib Efficacy in NSCLC Patients with High Polysomy of Chromosome 7 and EGFR/KRas Wild-Type Tumors

Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires—an Italian exploratory study

Homeopathy and Complementary Integrative Medicine, Dietary and Lifestyle Advices to Reduce Adverse-Effects of Anti-Cancer Therapy: A Cohort Study with Breast Cancer Patients

P3.02c-094 Italian Nivolumab Advanced Squamous NSCLC Expanded Access Program: Efficacy and Safety in Patients with Brain Metastases

P2.01-044 Baseline Peripheral Blood Cell Subsets Associated with Survival Outcomes in Advanced NSCLC Treated with Nivolumab in Second-Line Setting

Suchergebnisse filtern